Evidence map›Paper›PMID 38503816›Full record

ArticleScientific reports2024

Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study.

Gilles Kayem, Aurélien Seco, Francoise Vendittelli, Catherine Crenn Hebert, Corinne Dupont, Bernard Branger, Cyril Huissoud, Jeanne Fresson, Norbert Winer, Bruno Langer and 14 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
30.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pathophysiology and Management of Placenta Accreta Spectrum.Journal of developmental biology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prevalence and risk factors for placenta previa in a specialty hospital.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 18 institutions in 3 countries.

Gilles KayemTrousseau Hospital, APHP, Sorbonne University, Paris, France. gkayem@gmail.com.
Aurélien SecoClinical Research Unit Necker Cochin, APHP, Paris, France.
Francoise VendittelliRéseau de Santé en Périnatalité d'Auvergne, Clermont-Ferrand, France.
Catherine Crenn HebertAPHP, Louis Mourier University Hospital, Colombes, France.
Corinne DupontUniversity Claude Bernard Lyon 1, RESHAPE INSERM U1290, Univ. Lyon, 7425, Lyon, France.
Bernard BrangerRéseau « Sécurité Naissance - Naître Ensemble » des Pays-de-la-Loire, Nantes, France.
Cyril HuissoudRéseau Périnatal Aurore, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France.
Jeanne FressonCRESS U1153, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology (EPOPé) Research Team, Paris University, Paris, France.
Norbert WinerService de Gynécologie Obstétrique HME Université de Nantes, NUN, INRA, UMR 1280, Phan, Université de Nantes, 44000, Nantes, France.
Bruno LangerCHU de Strasbourg, Strasbourg, France.
Patrick RozenbergCHI de Poissy, Poissy, France.
Olivier MorelCHRU de Nancy, Nancy, France.
Marie Pierre BonnetCRESS U1153, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology (EPOPé) Research Team, Paris University, Paris, France.
Franck PerrotinCHRU de Tours, Tours, France.
Elie AzriaCRESS U1153, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology (EPOPé) Research Team, Paris University, Paris, France.
Lionel CarbillonRéseau Périnatal NEF Naître dans l'Est Francilien, Paris 13 University, Villetaneuse, France.
Coralie ChiesaCRESS U1153, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology (EPOPé) Research Team, Paris University, Paris, France.
Pierre RaynalCH de Versailles, Site Andre Mignot, Versailles, France.
René Charles RudigozRéseau Périnatal Aurore, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France.
Sophie PatrierCHU de Rouen, Rouen, France.
Gaël BeucherService de Gynécologie Obstétrique et Médecine de la Reproduction, CHU de Caen, Avenue Côte de Nacre, Caen Cedex 9, France.
Michel DreyfusService de Gynécologie Obstétrique et Médecine de la Reproduction, CHU de Caen, Avenue Côte de Nacre, Caen Cedex 9, France.
Loïc SentilhesDepartment of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France.
Catherine Deneux-TharauxCRESS U1153, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology (EPOPé) Research Team, Paris University, Paris, France.
Inserm · FRCentre Hospitalier Universitaire de Caen Normandie · FRHôpital de la Croix-Rousse · FRCentre Hospitalier de Versailles · FRCentre Hospitalier Intercommunal de Poissy · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Rouen · FRCentre Hospitalier Universitaire de Tours · FRCentre National de la Recherche Scientifique · FRÉcole Nationale Supérieure d'Architecture de Nantes · FRHôpital Cochin · FRHôpital Jean-Verdier · FRHôpital Louis-Mourier · FRHôpitaux Universitaires de Strasbourg · FRSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Bordeaux · FR

Funding

Ministère de la santé et de la recherche AOR12156; 12/ 19/2013
6 · The paper itself

Abstract

This study aimed to identify the risk factors for placenta accreta spectrum (PAS) in women who had at least one previous cesarean delivery and a placenta previa or low-lying. The PACCRETA prospective population-based study took place in 12 regional perinatal networks from 2013 through 2015. All women with one or more prior cesareans and a placenta previa or low lying were included. Placenta accreta spectrum (PAS) was diagnosed at delivery according to standardized clinical and histological criteria. Of the 520,114 deliveries, 396 fulfilled inclusion criteria; 108 were classified with PAS at delivery. Combining the number of prior cesareans and the placental location yielded a rate ranging from 5% for one prior cesarean combined with a posterior low-lying placenta to 63% for three or more prior cesareans combined with placenta previa. The factors independently associated with PAS disorders were BMI ≥ 30, previous uterine surgery, previous postpartum hemorrhage, a higher number of prior cesareans, and a placenta previa. Finally, in this high-risk population, the rate of PAS disorders varies greatly, not only with the number of prior cesareans but also with the exact placental location and some of the women's individual characteristics. Risk stratification is thus possible in this population.

Indexed as

Placenta AccretaPlacenta PreviaCesarean SectionFemaleHumansPlacentaPregnancyProspective StudiesRetrospective StudiesRisk Factors

Identifiers

PMID38503816
PMCPMC10951207
OpenAlexW4392956006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.